Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT04996953
Other study ID # KUN0802
Secondary ID
Status Enrolling by invitation
Phase
First received
Last updated
Start date June 1, 2021
Est. completion date July 1, 2025

Study information

Verified date August 2021
Source Qianfoshan Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

All the subjects were assessed for sleep quality, anxiety and depression, and cognitive function. Based on their previous hypnotic medication history, they were divided into a non-medicine group and a benzodiazepine group,and the group taking non-benzodiazepine drugs.The cognitive effects of different hypnotic drugs on patients were evaluated by comparing sleep related scale and cognitive function scale.


Description:

Insomnia is one of the most common sleep disorders, with 38.2% of Chinese people suffering from sleep disorders. There are many ways to treat insomnia disorders, but drug therapy is the most commonly used method by medical staff. The cognitive effects of sleep drugs vary in numerous studies, depending on the type and dosage of drugs.This study aims to explore the effects of different types of hypnotic drugs on the treatment of insomnia and cognitive function, hoping to improve the sleep quality and living standards of insomnia patients through this study, and also to obtain some cognitive impairment prevention measures related to insomnia, to provide some theoretical basis for clinical treatment.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 165
Est. completion date July 1, 2025
Est. primary completion date July 1, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: 1. Signed informed consent, male or female =18 and =75 years old; 2. (ICSD-3) proposed the diagnostic criteria for chronic insomnia; 2. Did not take hypnotic drugs before the visit; 3. Those who took hypnotic drugs before the visit; 4. Can understand and comply with the study protocol; Exclusion Criteria: 1. Severe organic disease; 2. Any suicidal behavior in the past 10 years; 3. Those who cannot communicate normally cannot cooperate to complete the scale test; 4. Women who are breastfeeding or pregnant; 5. Medical history that the investigator believes could affect the safety of the subject or interfere with the study evaluation; 6. Currently diagnosed with sleep apnea, narcolepsy and other sleep disorders; 7. Sleep disorders caused by central nervous system diseases, or neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease, lewy bodies dementia.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
China The First Affiliated Hospital of Shandong First Medical University Jinan Shandong

Sponsors (1)

Lead Sponsor Collaborator
Lili Cao

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pittsburgh sleep quality index scale The sleep quality of the patients in the past month was evaluated. The higher the score, the worse the sleep quality. The scale of the score is 0-21, and the higher score means a worse outcome. 1 day
Primary Epworth Sleeping Scale Assess the possibility of dozing (not just feeling tired) in recent months. The higher the score was, the more likely it was to doze during the day. The scale of the score is 0-24, and the higher score means a worse outcome. 1 day
Primary Insomnia Severity Index Liker scale is used to evaluate the nature and symptoms of sleep disorders. The higher the score, the more serious the insomnia. The scale of the score is 0-28, and the higher score means a worse outcome. 1 day
Primary Hamilton Anxiety Scale It can be used to evaluate the depressive symptoms of depression, manic depression, neurosis and other diseases. The scale of the score is 0-56, and the higher score means a worse outcome. 1 day
Primary Hamilton Depression Scale It can be used to evaluate the depressive symptoms of depression, manic depression, neurosis and other diseases. The higher the score, the more severe the depression. The scale of the score is 0-96, and the higher score means a worse outcome. 1 day
Primary The Word Learning Scale used to evaluate the subjects from two aspects of immediate recall and long-term delayed recall. The evaluation content included 15 words in five categories: body parts, animals, tools, vehicles and furniture. The 15 words were first presented three times.The score of immediate recall was the total number of words recalled three times, and the score of short-term delay recall was the correct number of free recall after 2min.Among them, immediate memory lower than 18 indicates that immediate memory function is impaired, and delayed memory lower than 6 indicates that delayed memory is impaired.the higher scores mean a better outcome. 1 day
Primary The verbal Fluency Scale They were asked to name as many animals, fruits and vegetables as possible in a 60-second experiment,the higher scores mean a better outcome. 1 day
Primary The Numeral-Sign Conversion Test Scale The tester placed the test in front of the subject, with a number above it and a symbol below it, with a different symbol for each number.Subjects were given 90 seconds to fill each space with a symbol that matched the sample, and were given one point for each symbol that matched, the higher the score, the better. 1 day
Primary Digital Span Test Scale To assess the subjects' attention span, forward and backward number spans were the subjects' ability to recite a series of numbers in the correct order.Participants were asked to repeat a series of random numbers in reverse order, reading each number for one second.Participants were asked to repeat the number in reverse order.Each set of numbers was randomly composed of the numbers 1 to 9, and the highest success score was calculated.The most successful scores were back-to-back 10 points and back-to-back 8 points.The higher the score, the better. 1 day
Primary Stroop Color Word Test Scale The executive ability of the subjects was assessed by the number of questions correctly answered by the subjects within 1min, which was divided into three types of cards: A, B and C, and each card had 100 items.Subjects correctly read the total number of red, blue, and green color names printed in black on card A within 1min, correctly identify the total number of red, blue, and green color backgrounds on card B within 1min, and correctly read the total number of different colors with red, blue, and green names on card C within 1min.For all parts of the Stroop test, the result is the time required to complete the C-card task, and the correct number, which is a kind of executive function test.The longer it takes, the worse the result, the higher the correct number, the better. 1 day
Primary Trail Making Test A and B Scale Test A: Show the numbers from 1 to 25. They are randomly distributed. Connect them in the order of 1, 2, 3, all the way to 25.Test B: There are numbers 1 to 13, black and white, respectively, in the order of the color black and white cameras, such as white 1 with black 1, black 1 with white 2, white 2 with black 2, all the way to 13.the higher scores mean a worse outcome. 1 day
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05561829 - Determination of Optimal Sleep Treatment Elements - MOST N/A
Completed NCT05561790 - Determination of Optimal Sleep Treatment Elements - Pilot N/A
Recruiting NCT06053840 - An Open-label Trial to Evaluate the Safety and Efficacy of Chloral Hydrate in Patients With Severe Insomnia Phase 4
Terminated NCT04059302 - Internet Cognitive Behavioral Therapy for Insomnia to Prevent Cardiovascular Disease N/A
Recruiting NCT04545606 - Targeting Insomnia in School Aged Children With Autism Spectrum Disorder N/A
Completed NCT04073992 - Chronic Insomnia and CSF Markers of Dementia - Effects of Treatment N/A
Completed NCT03623438 - Self-administered Acupressure for Insomnia Disorder N/A
Completed NCT04565223 - Feasibility and Acceptability of Cognitive Behavioral Therapy for Chronic Insomnia in a Primary Care N/A
Not yet recruiting NCT06351839 - Sleep Well Despite Persistent Pain Symptoms N/A
Completed NCT05078112 - Sleep Device Testing N/A
Active, not recruiting NCT05917379 - The Safety and Efficacy of FMT in Patients With CID Phase 1/Phase 2
Active, not recruiting NCT04627480 - Evaluation of a Neurostimulation Device for Insomnia: A Randomized Trial Phase 4
Completed NCT03441191 - Audio-visual Stimulation for Sleep Promotion in Older Adults With Osteoarthritis Pain N/A
Completed NCT04406103 - Protocol - Your Answers When Needing Sleep in New Brunswick N/A
Recruiting NCT05373537 - Treatment to Improve Sleep in Caregivers With Insomnia and a Child With Autism N/A
Recruiting NCT05797324 - Light Therapy in Modulating the Clinical Phenotype of Patients With Primary and Comorbid Chronic Insomnia. N/A
Completed NCT02967185 - Intraindividual Variability in Sleep and Cognitive Performance in Older Adults Phase 2
Recruiting NCT06410495 - Digital Dyadic Family Based Intervention to Improve Sleep in Children With ODD and Their Parents: NiteCAPP SINCC (Pilot) N/A
Completed NCT03015766 - Auricular Acupressure for Hemodialysis Patients With Insomnia N/A
Completed NCT03482856 - Cognitive Behavioural Therapy for Insomnia in Chronic Spinal Pain N/A